FDA Adverse Event Malfunction Summary report: N

PENUMBRA COIL 400

MDR report key: 14525483 · Received May 27, 2022

Report

Report Number
3005168196-2022-00235
Event Type
Malfunction
Date Received
May 27, 2022
Date of Event
November 1, 2017
Report Date
May 27, 2022
Manufacturer
PENUMBRA, INC.
Product Code
HCG
PMA / PMN Number
K120330
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PE
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE PRODUCT WAS NOT RETURNED FOR EVALUATION. WITHOUT THE RETURN OF THE DEVICE, THE ROOT CAUSE OF THE PROBLEM CANNOT BE DETERMINED. THE PRODUCT LOT NUMBER WAS NOT PROVIDED, THEREFORE, THE MANUFACTURING RECORDS COULD NOT BE REVIEWED.

Description of Event or Problem · 0

DURING ITS POST-MARKET SURVEILLANCE ACTIVITIES ON 03-MAY-2022, PENUMBRA INC. BECAME AWARE OF A JOURNAL ARTICLE TITLED, "ENDOVASCULAR TREATMENT OF MEDIUM AND LARGE INTRACRANIAL ANEURYSMS WITH LARGE VOLUME COILS: A SINGLE CENTER EXPERIENCE" (SAAL-ZAPATA ET AL. 2022). IN THIS SINGLE CENTER RETROSPECTIVE REVIEW, THIRTY-THREE PATIENTS WITH RUPTURED AND UNRUPTURED INTRACRANIAL ANEURYSMS WERE TREATED BETWEEN NOVEMBER 2017 AND SEPTEMBER 2019 USING PENUMBRA COIL 400S (PC400S), A PENUMBRA COIL DETACHMENT HANDLE (HANDLE), A PX SLIM DELIVERY MICROCATHETER (PX SLIM), A NEURON MAX 6F 088 LONG SHEATH (NEURON MAX) AND A GUIDEWIRE (0.014¿). ONE PATIENT WHO UNDERWENT A STENT-ASSISTED COILING (SAC) PROCEDURE TO TREAT AN UNRUPTURED PARACLINOID ANEURYSM USING PC400S EXPERIENCED AN INTRAPROCEDURAL COIL PROTRUSION INTO THE PARENT ARTERY. STENT PLACEMENT WAS REQUIRED IN ORDER TO AVOID PARENT ARTERY OCCLUSION. IT WAS NOT POSSIBLE TO ASCERTAIN SPECIFIC DEVICE INFORMATION FROM THE ARTICLE, NOR TO MATCH THE EVENTS REPORTED WITH PREVIOUSLY REPORTED COMPLAINTS. THEREFORE, THIS REPORT ADDRESSES ALL MALFUNCTIONS AND/OR ADVERSE EVENTS WITHIN THIS LITERATURE SOURCE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2193906 PENUMBRA COIL 400 HCG, KRD HCG PENUMBRA, INC.

Patients

Seq Age Sex Outcome Treatment
1 36 YR Female